Additive Orthopaedics Gains FDA Clearance of Patient Specific 3D Printed Bone Segments

Additive Orthopaedics received FDA 510(k) clearance to market Patient Specific 3D-Printed Bone Segments for ankle and foot fixation.

Per leadership, the company's lattice structures have shown close to 90% bony ingrowth after 6 months, with no use of biologics.

Over 1,000 of the company's devices have been implanted since commercial launch...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us